Skip to main content
. 2012 Jun 27;14(4):677–687. doi: 10.1208/s12248-012-9383-0

Fig. 4.

Fig. 4

Pharmacokinetic comparison of a nanosuspension to other FIH formulation candidates for Merck compound A. The nanosuspension provides the highest exposure compared to either a liquid-filled capsule or a solid dispersion formulation